Hint mode is switched on Switch off

Vir Biotechnology, ordinary share
VIR, US92764N1028

Add a stock to WL
Choose all Reset all
Vir Biotechnology, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Vir Biotechnology, Inc. operates as a clinical-stage immunology company. The Company develops and commercializes therapeutics and medicines for the treatments and preventions for viral and bacterial diseases. Vir Biotechnology serves customers in the State of California.
  • Issuer
  • Full borrower / issuer name
    Vir Biotechnology Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIR
  • Placement
    11.10.2019
  • Lock up period
    180
  • Number of papers
    7,142,858
  • Volume of raised funds
    142.86 mln USD
  • Placement share
    6.53%
  • Final placement price
    20 USD
  • Price change since placement date
    -100%
  • By capitalization
    2,187.94 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VIR
  • Placement
    08.07.2020
  • Lock up period
    180
  • Number of papers
    7,142,857
  • Volume of raised funds
    300 mln USD
  • Placement share
    5.79%
  • Final placement price
    42 USD
  • Price change since placement date
    -79%
  • By capitalization
    5,184.57 mln USD

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

25/05/2026 Vir Biotechnology: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders
26/02/2026 Vir Biotechnology: Other Events
25/02/2026 Vir Biotechnology: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
23/02/2026 Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
19/02/2026 Vir Biotechnology: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.